A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies
暂无分享,去创建一个
M. Solh | S. Solomon | A. Bashey | L. Morris | Xu Zhang | H. Holland | Gabriel Hinojosa | J. LaPorte